Among adolescents, the presentation of obstructive sleep apnea syndrome (OSAS) mirrors many typical signs of a much more common age-related diagnosis — hyperactivity, decreased attention span and ...
COPD Infection Management and Mitigation Strategies: Focusing on Diagnostics and Targeted Treatments
As the “Swiss Army knife of bacteria,” methicillin-resistant Staphylococcus aureus is quite the problematic organism, said John Osiecki, PhD. Among the diverse group of gram-positive bacteria ...
Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...
Having recently scored approval for Nucala in chronic obstructive pulmonary disease (COPD), GSK has now signed a major $12 billion biobucks deal designed to strengthen the pharma’s offering for the ...
Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken a hit after the anti-ST2 monoclonal antibody failed to reduce flare-ups in ...
Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death from disease — on track to be the third by 2035 if nothing changes. Gaps in ...
Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as those of smokers without the disease. These overloaded cells are larger and ...
Incorporating chest CT imaging and respiratory symptoms into the chronic obstructive pulmonary disease (COPD) diagnostic schema improved identification of individuals with poor respiratory outcomes, ...
Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive pulmonary disease (COPD)-associated ...
Mepolizumab is a humanized monoclonal antibody that targets interleukin-5, a cytokine that plays a central role in eosinophilic inflammation, which is present in 20 to 40% of patients with chronic ...
Who helps you manage your COPD? It’s more than just one doctor. It’s a medical care team. What Kind of Doctors Treat COPD? Your COPD care team includes providers who prescribe medicine, guide therapy ...
SGLT2 inhibitors and GLP-1 receptor agonists were associated with fewer exacerbations of COPD in adults with type 2 diabetes. There was little difference between SGLT2 inhibitors and GLP-1 receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback